Displaying results 37 - 48 of 73
Liver Tumours
Lipid and cell cycling perturbations driven by the HDAC inhibitor romidepsin render liver cancer vulnerable to receptor tyrosine kinase targeting and immunologically active

Lipid and cell cycling perturbations driven by the HDAC inhibitor romidepsin render liver cancer vulnerable to receptor tyrosi...

ePosters
View
Liver Tumours
Lipid involvement in modeling macrophage phenotype in primary liver cancer

Lipid involvement in modeling macrophage phenotype in primary liver cancer

ePosters
View
Liver Tumours
Immune biomarkers and their network of connections in patients with hepatocellular carcinoma and liver cirrhosis associated with hepatitis C virus

Immune biomarkers and their network of connections in patients with hepatocellular carcinoma and liver cirrhosis associated wi...

ePosters
View
Liver Tumours
Incidence and prevalence of hepatocellular carcinoma in patients coinfected with HBV and HDV.

Incidence and prevalence of hepatocellular carcinoma in patients coinfected with HBV and HDV.

ePosters
View
Liver Tumours
Inhibition of Strawberry Notch 1 represses hepatobiliary carcinoma development

Inhibition of Strawberry Notch 1 represses hepatobiliary carcinoma development

ePosters
View
Liver Tumours
In-situ vaccination with Flt3L elicits immune responses against hepatocellular carcinoma and synergizes with checkpoint blockade therapy

In-situ vaccination with Flt3L elicits immune responses against hepatocellular carcinoma and synergizes with checkpoint blocka...

ePosters
View
Liver Tumours
Integrated Single-Cell RNA and Chromatin Accessibility profiling reveals epigenetic drivers of tumor heterogeneity in cholangiocarcinoma

Integrated Single-Cell RNA and Chromatin Accessibility profiling reveals epigenetic drivers of tumor heterogeneity in cholangi...

ePosters
View
Liver Tumours
Epigenetic regulation of liver endothelial cells as a novel target to boost immunotherapy efficacy in hepatocellular cancer

Epigenetic regulation of liver endothelial cells as a novel target to boost immunotherapy efficacy in hepatocellular cancer

ePosters
View
Liver Tumours
Evaluating microbeam radiotherapys effect on normal liver tissue: a step towards understanding its potential as a treatment

Evaluating microbeam radiotherapys effect on normal liver tissue: a step towards understanding its potential as a treatment

ePosters
View
Liver Tumours
Evaluation of the effect of 35-dimaleamylbenzoic acid on preneoplastic lesions in a model of chemical hepatocarcinogenesis.

Evaluation of the effect of 35-dimaleamylbenzoic acid on preneoplastic lesions in a model of chemical hepatocarcinogenesis.

ePosters
View
Liver Tumours
Exploring the impact of mitochondrial biomarkers on HCC risk according to etiologic drivers: a multicenter study.

Exploring the impact of mitochondrial biomarkers on HCC risk according to etiologic drivers: a multicenter study.

ePosters
View
Liver Tumours
Harnessing human immune system mouse models to validate NOX1 inhibition as a treatment for hepatocellular carcinoma

Harnessing human immune system mouse models to validate NOX1 inhibition as a treatment for hepatocellular carcinoma

ePosters
View